A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a County hospital

Scandinavian Journal of Rheumatology

Volumn 26, Issue 6, 1997, Pages 440-443

  Sokka, T M ^a   Kautiainen, H J ^b   Hannonen, P J ^a  

^a Central Hospital   (Finland)

^b Finland MedCare Ltd   (Finland)

Author keywords

Combination therapy; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; CYCLOSPORIN A; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PODOPHYLLOTOXIN; SALAZOSULFAPYRIDINE;

ADULT; AGED; ALOPECIA; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SURVIVAL TIME;

EID: 0031451583     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709065716     Document Type: Article

References (29)

1. Scott DL, Dawes PT, Tunn E, et al. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomised, placebo-controlled study. Br J Rheumatol 1989;28:128-33.
2. Borigini MJ, Paulus HE. Combination therapy. In: Brooks PM, Furst DE, eds. Baillière's Clinical Rheumatology: Innovative Treatment Approaches for Rheumatoid Arthritis. London: WB Saunders 1995:689-710.
3. Furst DE. Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis. J Rheumatol 1996;23 Suppl 44:86-90.
4. Paulus HE. Protocol development for combinaton therapy with disease-modifying antirheumatic drugs. Semin Arthritis Rheum 1993;23 Suppl 1:19-25.
5. McCarty DJ, Carrera GF. Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azatioprine and hydroxychloroquine. JAMA 1982;248:1718-23.
6. Csuka M, Carrera GF, McCarthy DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azatioprine and hydroxychloroquine. A follow-up study. JAMA 1986;255:2315-9.
7. Taggart AJ, Hill J, Astbury C, Dixon JS, Bird HA, Wright V. Sulphasalazine alone or in combination with d-penisillamine in rheumatoid arthritis. Br J Rheumatol 1987;26:32-6.
8. Gibson T, Emery P, Amstrong RD, Crisp AJ, Panayi GS. Combined d-penisillamine and chloroquine treatment of rheumatoid arthritis: a comparative study. Br J Rheumatol 1987;26:279-84.
9. Haagsma CJ, Van Riel CM, De Rooij D. Combination of methotrexate and Sulphasalazine versus methotrexate alone: a randomised open clinical trial in rheumatoid arthritis patient resistant to Sulphasalazine therapy. Br J Rheumatol 1994;33:1049-55.
10. Williams HJ, Ward JR, Reading JC, et al. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthitis: a controlled clinical trial. Arthritis Rheum 1992;35:259-69.
11. Willkens RF, Urowitz MB, Stablein DM, et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1992;35:849-56.
12. Willkens RF, Sharp JE, Stablein DM, et al. Comparison of azathioprine, methotrexate and the combination of both in the treatment of rheumatoid arthritis: A 48 week controlled clinical trial with radiologie outcome assessment. Arthritis Rheum 1995;38:1799-1806.
13. Luthra HS. Midwest Cooperative Rheumatic Disease Study Group: Double-blind study comparing auranofin and hydrozychloroqine alone and in combination in rheumatoid arthritis (abstract). Arthritis Rheum 1990;Suppl 33: S25.
14. Faarvang KL, Egsmose C, Kruger P. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomized double blind trial. Ann Rheum Dis 1993;52:711-5.
15. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
16. O'Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulphasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
17. Clegg DO for the Hydroxychloroquine-Methotrexate Study Group. Combination hydroxychloroquine and methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1993;36: S53 (abstract).
18. McKenna F, Hopkins R, Hinchcliffe KP, et al. Gold and penicillamine, alone and in combination in active rheumatoid arthritis (abstract). 16th International Congress of Rheumatology, 1985. Sydney, Australia.
19. Bunch TW, O'Duffy JD, Tompkins RB, O'Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984;27:267-76.
20. Van Rijthoven AW, Dijkmans BA. Goei The HS, et al. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: A randomized, double blind, multicenter study. J Rheumatol 1991;18:815-20.
21. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A metaanalysis. Arthritis Rheum 1994;37:1487-91.
22. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
23. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 1990;17:12-5.
24. Möttönen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum 1996;39:996-1005.
25. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
26. Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. In: Brooks PM, Furst DE, eds. Bailliere's Clinical Rheumatology: Innovative treatment approaches for rheumatoid arthritis. London: WB Saunders 1995:619-32.
27. Morgan SL, Baggot JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:833-41.
28. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-82.
29. Barthel HR, Burmester GR. Specific drugs for a complex disease: can there be a magic bullet against rheumatoid arthritis? Ann Rheum Dis 1995;54:948-50.